Neurology News

A new report showed that about 15 million Americans who enrolled in Medicaid during the public health emergency could lose coverage when the emergency declaration ends.

Investigators should increase racial and geographic diversity and in-depth biomarker studies in dementia research to be more representative of routine practice to improve diagnosis and development of treatment for dementia.

In conjunction with World Alzheimer’s Day, Healio Psychiatry has compiled a list of articles covering recent research developments related to Alzheimer’s disease.

Neurolign announced the launch of NeurolignFit, a consumer health and wellness device with eye-tracking technology that allows users to track and improve their overall mental acuity.

BridgeBio Pharma Inc. announced it has received FDA fast track designation for BBP-418 as a treatment option for limb-girdle muscular dystrophy type 2i.

Later idiopathic intracranial hypertension diagnoses occurred less often in women with slightly lower cerebrospinal fluid opening pressure and fewer headaches, according to a retrospective, clinical cohort study.

Among 410 leading medical journals, just 21% had a woman as editor in chief, according to findings published in JAMA Network Open.

The FDA recommended health care providers and individuals avoid using compounded products said to be “sterile, produced and distributed nationwide by Prescription Labs Inc.” that does business as Greenpark Compounding Pharmacy.

Sage Therapeutics Inc. announced it has received FDA fast track designation for SAGE-718 as a potential treatment for Huntington’s disease.

Annual strokes and related deaths increased significantly between 1990 and 2019, despite significant reductions in age-standardized rates, according to a systematic analysis published in The Lancet Neurology.